CAC
AEON.WS

Cowen and Company’s AEON Biopharma Inc AEON.WS Stock Holding History

Cowen and Company’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-231,860
Closed -$23.2K – 752
2023
Q4 		$23.2K Sell
231,860
-100
-0% -$7 ﹤0.01% 331
2023
Q3 		$34.8K Sell
231,960
-75,628
-25% -$10.7K ﹤0.01% 320
2023
Q2 		$27.7K Buy
307,588
+23,400
+8% +$1.76K ﹤0.01% 300
2023
Q1 		$15.6K Buy
284,188
+16,666
+6% +$962 ﹤0.01% 329
2022
Q4 		$12.2K Buy
+267,522
New +$10.8K ﹤0.01% 389
2021
Q4 		– Sell
-20,782
Closed -$12K – 796
2021
Q3 		$12K Sell
20,782
-4,218
-17% -$3.09K ﹤0.01% 518
2021
Q2 		$25K Buy
+25,000
New +$19K ﹤0.01% 471

Other funds holding AEON.WS

DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return

Cowen and Company's AEON.WS Position: Q1 2024 in Review

Cowen and Company sold out of AEON Biopharma Inc (AEON.WS) in Q1 2024, closing a stake of 231,860 shares — an estimated $23.2K sold.

Cowen and Company first reported a position in AEON.WS in Q2 2021 and held it in 7 quarters. The position peaked at $34.8K in Q3 2023. 30 funds tracked by Wall St. Rank hold AEON.WS as of Q1 2024.

  • Cowen and Company reported no remaining AEON Biopharma Inc position as of Q1 2024 after selling out during the quarter.
  • Cowen and Company sold 231,860 AEON Biopharma Inc shares in Q1 2024, an estimated $23.2K.
  • Cowen and Company first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 7 quarters.
  • Cowen and Company's AEON Biopharma Inc position peaked at $34.8K in Q3 2023.
  • 30 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q1 2024.

Based on Cowen and Company's 13F filing for Q1 2024, filed 3 May 2024.